MAP 9.46% 16.8¢ microba life sciences limited

$678 million profit in 2006

  1. 241 Posts.
    people quoting these figures obviously dont know that all this profit is superficial and made up of asset revaluations. This benefits MBL more than MAp in case you dont know.

    The cash profit isn't anywhere near 600m (maybe 10% of it), so much so that cash is drawndown to fund the dividend ala MIG (the DRP also helps mask things too).

    I would also like to see how the IFRS introduced next year deals with these revaluations.
 
watchlist Created with Sketch. Add MAP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.